<
>
Dapagliflozin (461432-26-8)
Product Summary
Dapagliflozin is the first approved SGLT2 inhibitor for the treatment of type II diabetes, which is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes. Product Name: Dapagliflozin CAS No.: 461432-26-8 Assay: 99% Specification: CP, EP, In-house, as ...
Product Custom Attributes
CAS::
461432-26-8
Specification:
CP, EP, In-house, As Required
M.F.:
C21H25ClO6
M.W.:
408.88
Assay:
99%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Dapagliflozin 461432-26-8
,Dapagliflozin API Diabetics
,CAS: 461432-26-8 Dapagliflozin API
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS: 461432-26-8; Dapagliflozin manufaturer; Dapagliflozin API; Diabetics
Payment Terms:
T/T, L/C
Product Description
Dapagliflozin is the first approved SGLT2 inhibitor for the treatment of type II diabetes, which is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.
| Product Name: | Dapagliflozin |
| CAS No.: | 461432-26-8 |
| Assay: | 99% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C21H25ClO6 |
| Molecular Weight: | 408.88 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Related Products
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
